Igor van Santen

Igor van Santen is the CFO at KD Pharma Group. He has worked in various geographies and industries, including Base Chemicals, Specialty Ingredients, Fine Chemicals, Pharma, and Nutraceuticals, across North America, the Netherlands, and the DACH region. He joined KD Pharma 7 years ago. After merging with DSM Firmenich’s Marine Lipid business, KD Pharma has 710 employees in 12 countries, with €360M in revenue.